Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.07 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.45.
Market Cap
9.07T
Revenue
4.67T
Profits
191.06B
PE Ratio
47.45
Profit Margin
4.10%
Dividend Yield
0.40%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | -1.61% | 3,079,239 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 618.09B | -0.76% | 6,021,089 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 481.40B | 0.39% | 5,492,290 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 351.28B | -0.29% | 7,999,901 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 332.96B | -1.34% | 7,281,285 | 450.53B |
| 6 | NVS | Novartis AG | 268.27B | -0.12% | 1,532,554 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 241.70B | -0.84% | 3,488,725 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 241.07B | -1.52% | 2,585,460 | 46.34B |
| 9 | AMGN | Amgen Inc. | 220.28B | -1.37% | 2,365,247 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 182.40B | 0.17% | 4,489,135 | 30.46B |
| 11 | ABT | Abbott Laboratories | 170.43B | -0.24% | 13,909,197 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 165.25B | -0.21% | 11,808,372 | 50.34B |
| 13 | PFE | Pfizer Inc. | 158.56B | -0.64% | 44,318,973 | 63.70B |
| 14 | DHR | Danaher Corporation | 152.87B | -0.47% | 5,292,543 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 146.76B | 0.21% | 2,533,250 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.55B | -0.47% | 1,487,882 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.70B | -0.20% | 13,070,591 | 49.19B |
| 18 | CVS | CVS Health Corporation | 112.29B | -0.17% | 7,806,582 | 412.65B |
| 19 | MDT | Medtronic plc | 112.24B | 2.62% | 105,762,144 | 37.54B |
| 20 | MCK | McKesson Corporation | 108.46B | 2.19% | 715,607 | 410.98B |
| 21 | SYK | Stryker Corporation | 106.24B | 0.57% | 2,981,938 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 96.35B | 1.33% | 1,127,256 | 78.01B |
| 23 | SNY | Sanofi | 95.23B | 0.07% | 2,995,636 | 55.89B |
| 24 | GSK | GSK plc | 91.90B | -1.02% | 7,730,430 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 86.95B | -0.83% | 785,788 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 78.65B | 0.26% | 37,394,313 | 2.23B |
| 27 | CI | The Cigna Group | 74.26B | 0.90% | 969,839 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 73.85B | -0.34% | 500,234 | 15.53B |
| 29 | COR | Cencora, Inc. | 61.32B | 1.29% | 897,566 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 60.93B | 1.11% | 22,871,310 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.15B | 0.82% | 3,510,560 | 28.42B |
| 32 | NTRA | Natera, Inc. | 56.33B | -1.21% | 2,443,165 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.33B | 2.93% | 1,537,792 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 49.78B | 1.44% | 1,523,696 | 22.48B |
| 35 | EW | Edwards Lifesciences Corporation | 48.56B | -1.80% | 6,522,189 | 6.51B |
| 36 | A | Agilent Technologies, Inc. | 47.41B | -0.54% | 2,718,127 | 7.37B |
| 37 | MDLN | Medline Inc. | 46.99B | 0.82% | 10,191,253 | 29.94B |
| 38 | HUM | Humana Inc. | 46.49B | -2.37% | 2,656,082 | 145.68B |
| 39 | VEEV | Veeva Systems Inc. | 46.12B | 0.83% | 921,533 | 3.46B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 45.74B | 0.18% | 5,823,039 | 17.32B |
| 41 | ARGX | argenx SE | 43.57B | -11.83% | 2,475,063 | 5.32B |
| 42 | IQV | IQVIA Holdings Inc. | 42.61B | 0.30% | 988,332 | 16.98B |
| 43 | WAT | Waters Corporation | 42.16B | -1.57% | 1,043,811 | 4.64B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 40.43B | 1.28% | 696,672 | 4.55B |
| 45 | RVMD | Revolution Medicines, Inc. | 40.32B | -6.35% | 4,856,472 | - |
| 46 | HLN | Haleon plc | 40.08B | 2.66% | 20,283,935 | 14.80B |
| 47 | ILMN | Illumina, Inc. | 39.95B | -1.19% | 3,171,304 | 4.49B |
| 48 | ONC | BeOne Medicines AG | 39.81B | -3.82% | 408,968 | 6.13B |
| 49 | RPRX | Royalty Pharma plc | 32.32B | -0.97% | 2,847,234 | 2.54B |
| 50 | BIIB | Biogen Inc. | 32.27B | -1.67% | 1,339,041 | 10.03B |
| 51 | RMD | ResMed Inc. | 31.89B | 0.33% | 651,064 | 5.65B |
| 52 | CNC | Centene Corporation | 31.88B | -0.69% | 3,949,883 | 180.30B |
| 53 | DXCM | DexCom, Inc. | 31.85B | 0.13% | 3,607,070 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 30.65B | -0.26% | 264,552 | 4.13B |
| 55 | ALC | Alcon Inc. | 30.35B | 0.21% | 1,111,910 | 10.86B |
| 56 | ZTS | Zoetis Inc. | 30.20B | 2.14% | 6,175,254 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.04B | 0.05% | 1,771,672 | 4.80B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.01B | -0.70% | 4,954,931 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.57B | -0.88% | 461,694 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 25.48B | 0.71% | 703,725 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.48B | 1.65% | 941,866 | 11.56B |
| 62 | ROIV | Roivant Sciences Ltd. | 24.71B | -1.55% | 6,403,918 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 23.51B | 0.87% | 1,635,069 | 20.18B |
| 64 | BNTX | BioNTech SE | 23.13B | -3.35% | 1,205,421 | 3.03B |
| 65 | INCY | Incyte Corporation | 22.85B | -0.61% | 1,927,029 | 5.82B |
| 66 | UTHR | United Therapeutics Corporation | 22.85B | -2.24% | 722,523 | 3.15B |
| 67 | GH | Guardant Health, Inc. | 22.22B | -1.65% | 1,599,419 | 1.18B |
| 68 | INSM | Insmed Incorporated | 21.94B | -1.24% | 5,084,609 | 1.14B |
| 69 | THC | Tenet Healthcare Corporation | 20.98B | 0.28% | 428,008 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.75B | -1.64% | 4,299,812 | 4.13B |
| 71 | STE | STERIS plc | 20.55B | 0.52% | 498,396 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.03B | -0.29% | 14,109,967 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 16.98B | -0.94% | 1,456,900 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 16.95B | 0.44% | 2,530,917 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.82B | -0.26% | 223,102 | 2.78B |
| 76 | SOLV | Solventum Corporation | 14.71B | 0.62% | 780,710 | 8.31B |
| 77 | ASND | Ascendis Pharma A/S | 14.62B | -2.50% | 924,125 | 1.20B |
| 78 | EXEL | Exelixis, Inc. | 14.62B | 0.99% | 2,684,957 | 2.44B |
| 79 | JAZZ | Jazz Pharmaceuticals plc | 14.44B | -3.78% | 1,268,630 | 4.60B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.36B | -1.55% | 1,237,145 | 3.37B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.23B | -0.77% | 1,176,886 | 4.00B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.73B | -4.35% | 6,172,853 | - |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.26B | -0.22% | 2,052,343 | 14.37B |
| 84 | CORT | Corcept Therapeutics Incorporated | 12.81B | -0.89% | 496,613 | 830.81M |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.71B | -2.20% | 3,361,891 | 713.07M |
| 86 | ICLR | ICON Public Limited Company | 12.70B | 0.30% | 1,020,185 | 8.29B |
| 87 | PEN | Penumbra, Inc. | 12.51B | 0.37% | 379,358 | 1.50B |
| 88 | TEM | Tempus AI, Inc. | 12.50B | -1.52% | 7,456,040 | 1.43B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.47B | -0.86% | 2,490,334 | 1.66B |
| 90 | BAX | Baxter International Inc. | 12.36B | -0.29% | 7,561,469 | 11.47B |
| 91 | EHC | Encompass Health Corporation | 12.09B | 0.05% | 895,725 | 6.21B |
| 92 | TECH | Bio-Techne Corporation | 11.36B | -0.08% | 5,474,323 | 1.22B |
| 93 | DVA | DaVita Inc. | 11.29B | 0.14% | 582,175 | 14.01B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.26B | 0.81% | 4,570,386 | 5.02B |
| 95 | SNN | Smith & Nephew plc | 11.18B | 0.26% | 1,051,703 | 6.30B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.02B | -2.22% | 374,363 | 1.28B |
| 97 | FMS | Fresenius Medical Care AG | 11.00B | 0.92% | 1,467,512 | 22.19B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -0.56% | 1,536,253 | 3.41B |
| 99 | IBRX | ImmunityBio, Inc. | 10.50B | 1.64% | 9,738,804 | 165.79M |
| 100 | AVTR | Avantor, Inc. | 10.41B | 0.26% | 12,125,849 | 6.56B |
| 101 | UHS | Universal Health Services, Inc. | 10.36B | 0.63% | 429,198 | 18.11B |
| 102 | COO | The Cooper Companies, Inc. | 10.33B | -0.82% | 5,846,873 | 4.24B |
| 103 | OSCR | Oscar Health, Inc. | 10.21B | 0.58% | 4,132,682 | 15.32B |
| 104 | MOH | Molina Healthcare, Inc. | 10.20B | 0.48% | 789,497 | 42.47B |
| 105 | RDY | Dr. Reddy's Laboratories Limited | 10.09B | -0.57% | 3,834,427 | 3.50B |
| 106 | TXG | 10x Genomics, Inc. | 10.07B | 1.55% | 5,157,285 | 616.91M |
| 107 | ALGN | Align Technology, Inc. | 10.02B | 0.84% | 1,344,509 | 4.14B |
| 108 | ENSG | The Ensign Group, Inc. | 9.91B | 1.34% | 354,935 | 5.49B |
| 109 | GMED | Globus Medical, Inc. | 9.85B | -0.57% | 1,888,335 | 3.14B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.69B | 0.84% | 271,466 | 440.48M |
| 111 | PCVX | Vaxcyte, Inc. | 9.67B | -2.90% | 3,886,809 | - |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 9.64B | -2.04% | 231,135 | 2.59B |
| 113 | TWST | Twist Bioscience Corporation | 9.53B | -2.31% | 4,371,462 | 431.80M |
| 114 | GKOS | Glaukos Corporation | 9.51B | -6.32% | 2,891,750 | 612.84M |
| 115 | HSIC | Henry Schein, Inc. | 9.43B | 1.16% | 2,675,892 | 13.60B |
| 116 | PODD | Insulet Corporation | 9.33B | 0.08% | 1,546,509 | 3.05B |
| 117 | RGEN | Repligen Corporation | 9.25B | -2.02% | 1,226,289 | 785.10M |
| 118 | QGEN | Qiagen N.V. | 9.21B | -0.58% | 1,559,401 | 2.10B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.09B | 0.88% | 1,044,671 | 105.00M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.05B | -0.72% | 1,000,034 | 281.99M |
| 121 | AXSM | Axsome Therapeutics, Inc. | 8.91B | -1.67% | 1,073,628 | 776.57M |
| 122 | BRKR | Bruker Corporation | 8.82B | -3.01% | 2,555,977 | 3.50B |
| 123 | CYTK | Cytokinetics, Incorporated | 8.62B | 1.46% | 2,594,627 | 67.67M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.58B | -1.20% | 1,784,717 | 669.50M |
| 125 | HNGE | Hinge Health, Inc. | 7.91B | 0.14% | 908,680 | 720.06M |
| 126 | CAI | Caris Life Sciences, Inc. | 7.77B | 1.48% | 3,859,918 | 989.61M |
| 127 | ATR | AptarGroup, Inc. | 7.74B | 1.15% | 602,388 | 3.93B |
| 128 | ABVX | ABIVAX Société Anonyme | 7.70B | 2.34% | 2,027,090 | 5.33M |
| 129 | HQY | HealthEquity, Inc. | 7.70B | 1.25% | 772,769 | 1.36B |
| 130 | TGTX | TG Therapeutics, Inc. | 7.57B | 0.74% | 1,734,982 | 799.54M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -1.18% | 2,326,679 | - |
| 132 | PRAX | Praxis Precision Medicines, Inc. | 7.36B | -5.20% | 675,488 | 7.46M |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.20B | -1.95% | 3,349,195 | 874.09M |
| 134 | PACS | PACS Group, Inc. | 6.92B | 1.25% | 588,681 | 5.55B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.84B | - | 2,820,591 | 3.12B |
| 136 | ALKS | Alkermes plc | 6.73B | -3.22% | 3,251,027 | 1.67B |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.55B | -5.01% | 12,122,101 | 2.58B |
| 138 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.06% | 513,885 | 1.56B |
| 139 | CHE | Chemed Corporation | 6.48B | -0.64% | 135,452 | 2.60B |
| 140 | GRFS | Grifols, S.A. | 6.47B | -1.40% | 368,072 | 8.48B |
| 141 | IMVT | Immunovant, Inc. | 6.25B | -5.56% | 1,755,337 | - |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.17B | 1.35% | 1,008,516 | 239.92M |
| 143 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.14B | 1.01% | 411,538 | 840.85M |
| 144 | BLTE | Belite Bio, Inc | 6.13B | -2.51% | 154,319 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 6.13B | -1.10% | 358,671 | 5.32B |
| 146 | IOVA | Iovance Biotherapeutics, Inc. | 6.03B | 3.06% | 12,483,511 | 324.97M |
| 147 | GRAL | GRAIL, Inc. | 5.92B | -0.22% | 1,311,790 | 165.26M |
| 148 | KOD | Kodiak Sciences Inc. | 5.91B | 3.49% | 1,527,292 | - |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | 0.59% | 330,656 | 290.54M |
| 150 | CGON | CG Oncology, Inc. | 5.61B | 1.41% | 910,302 | 6.23M |
| 151 | MMED | MiniMed Group, Inc. | 5.57B | 3.61% | 23,336,073 | 3.22B |
| 152 | HAE | Haemonetics Corporation | 5.44B | 17.46% | 2,765,310 | 1.35B |
| 153 | ERAS | Erasca, Inc. | 5.41B | 9.49% | 9,533,538 | - |
| 154 | RDNT | RadNet, Inc. | 5.37B | -0.58% | 722,260 | 2.27B |
| 155 | MANE | Veradermics, Incorporated | 5.29B | 14.13% | 3,489,638 | - |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.28B | 0.88% | 664,285 | 618.07M |
| 157 | TFX | Teleflex Incorporated | 5.26B | -0.23% | 673,647 | 2.25B |
| 158 | STVN | Stevanato Group S.p.A. | 5.25B | -1.18% | 233,051 | 1.40B |
| 159 | DOCS | Doximity, Inc. | 5.24B | 6.10% | 5,196,141 | 655.57M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.22B | -1.06% | 1,171,399 | 1.01B |
| 161 | COGT | Cogent Biosciences, Inc. | 5.22B | -0.20% | 3,643,278 | - |
| 162 | SRRK | Scholar Rock Holding Corporation | 5.14B | - | 3,303,855 | - |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.11B | -2.87% | 1,224,945 | - |
| 164 | SHC | Sotera Health Company | 5.09B | -0.39% | 2,250,537 | 1.22B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.09B | 0.12% | 539,259 | 1.58B |
| 166 | WAY | Waystar Holding Corp. | 5.08B | 2.76% | 2,085,699 | 1.21B |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.91B | -2.62% | 1,647,161 | 591.33M |
| 168 | CRSP | CRISPR Therapeutics AG | 4.88B | -3.65% | 2,863,263 | 13.39M |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.67B | 0.58% | 1,185,302 | 2.29B |
| 170 | OPCH | Option Care Health, Inc. | 4.65B | 0.13% | 9,659,129 | 5.69B |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -2.89% | 1,003,695 | 1.90M |
| 172 | LFST | LifeStance Health Group, Inc. | 4.61B | -0.41% | 2,356,698 | 1.58B |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.59B | -2.59% | 2,104,223 | - |
| 174 | BLLN | BillionToOne, Inc. | 4.50B | -0.36% | 382,551 | 397.41M |
| 175 | ITGR | Integer Holdings Corporation | 4.31B | 0.05% | 1,140,515 | 1.84B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | -0.86% | 1,363,481 | - |
| 177 | LIVN | LivaNova PLC | 4.18B | 0.03% | 467,147 | 1.47B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.18B | -1.88% | 1,527,162 | 1.33B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.16B | -0.72% | 2,640,217 | 308.08M |
| 180 | HTFL | HeartFlow, Inc. | 4.14B | -3.50% | 1,984,254 | 212.07M |
| 181 | ICUI | ICU Medical, Inc. | 3.93B | 0.83% | 220,593 | 2.16B |
| 182 | ABCL | AbCellera Biologics Inc. | 3.90B | -6.31% | 8,178,319 | 66.17M |
| 183 | RLAY | Relay Therapeutics, Inc. | 3.82B | -3.01% | 4,332,020 | 10.35M |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.81B | 3.39% | 5,074,349 | 53.81M |
| 185 | RGC | Regencell Bioscience Holdings Limited | 3.78B | 7.31% | 223,213 | - |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.71B | -0.94% | 390,334 | 890.79M |
| 187 | NVST | Envista Holdings Corporation | 3.65B | -1.39% | 2,268,827 | 2.86B |
| 188 | LEGN | Legend Biotech Corporation | 3.63B | -2.14% | 2,150,057 | 1.27B |
| 189 | OGN | Organon & Co. | 3.61B | -0.29% | 2,089,486 | 6.13B |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.56B | 1.81% | 315,581 | 1.19M |
| 191 | NHC | National HealthCare Corporation | 3.53B | 1.80% | 82,206 | 1.56B |
| 192 | VCYT | Veracyte, Inc. | 3.51B | 1.02% | 1,218,622 | 561.90M |
| 193 | XENE | Xenon Pharmaceuticals Inc. | 3.50B | -0.69% | 2,097,482 | 7.50M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.55% | 548,701 | 234.13M |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.47B | -2.53% | 1,392,627 | 148.00K |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.41B | -0.84% | 1,720,015 | -665.00K |
| 197 | IRTC | iRhythm Holdings, Inc. | 3.38B | -2.28% | 668,288 | 825.34M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.37B | -0.36% | 1,065,673 | 1.14B |
| 199 | CELC | Celcuity Inc. | 3.32B | 3.18% | 2,590,809 | - |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.23B | -2.84% | 8,686,628 | - |
| 201 | CDNA | CareDx, Inc. | 3.22B | -1.32% | 1,571,211 | 458.09M |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | -1.89% | 642,109 | 606.33M |
| 203 | WRBY | Warby Parker Inc. | 3.08B | -1.42% | 2,831,895 | 911.61M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.08B | 1.32% | 2,605,917 | 463.98M |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.06B | 2.50% | 6,279,487 | - |
| 206 | RCUS | Arcus Biosciences, Inc. | 3.03B | -2.81% | 1,864,639 | 117.00M |
| 207 | DNLI | Denali Therapeutics Inc. | 2.98B | -2.56% | 2,366,244 | 3.60M |
| 208 | ELVN | Enliven Therapeutics, Inc. | 2.98B | -1.76% | 1,654,883 | - |
| 209 | ZLAB | Zai Lab Limited | 2.79B | -1.98% | 979,117 | 449.61M |
| 210 | TMDX | TransMedics Group, Inc. | 2.74B | -2.55% | 949,379 | 668.47M |
| 211 | PGEN | Precigen, Inc. | 2.72B | 0.80% | 3,829,305 | 85.72M |
| 212 | ATRC | AtriCure, Inc. | 2.69B | -0.88% | 595,646 | 569.62M |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.67B | -0.57% | 2,110,465 | 2.60B |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.65B | -2.57% | 1,301,420 | 3.37B |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.64B | 2.26% | 574,076 | 1.46B |
| 216 | BKD | Brookdale Senior Living Inc. | 2.60B | 1.11% | 5,022,112 | 2.93B |
| 217 | PRVA | Privia Health Group, Inc. | 2.58B | -0.54% | 1,556,353 | 2.36B |
| 218 | MBX | MBX Biosciences, Inc. | 2.56B | -2.37% | 413,811 | - |
| 219 | NEOG | Neogen Corporation | 2.56B | 0.26% | 8,669,718 | 884.00M |
| 220 | NAMS | NewAmsterdam Pharma Company N.V. | 2.54B | -3.93% | 1,665,043 | 7.12M |
| 221 | LQDA | Liquidia Corporation | 2.51B | 5.02% | 4,431,439 | 450.91M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.46B | -0.69% | 2,425,660 | 156.04M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.45B | -2.11% | 684,161 | 830.44M |
| 224 | CLOV | Clover Health Investments, Corp. | 2.43B | 0.44% | 5,284,860 | 2.48B |
| 225 | IRON | Disc Medicine, Inc. | 2.33B | -0.67% | 846,816 | - |
| 226 | ADMA | ADMA Biologics, Inc. | 2.31B | 1.87% | 3,902,777 | 512.28M |
| 227 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 0.66% | 803,215 | 959.90M |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.30B | -2.29% | 2,344,860 | 36.77M |
| 229 | CLDX | Celldex Therapeutics, Inc. | 2.30B | -3.71% | 3,950,413 | 158.00K |
| 230 | HCM | HUTCHMED (China) Limited | 2.30B | -4.27% | 45,079 | 549.12M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.27B | -0.44% | 4,182,006 | - |
| 232 | PBH | Prestige Consumer Healthcare Inc. | 2.27B | 0.63% | 558,477 | 1.10B |
| 233 | BHC | Bausch Health Companies Inc. | 2.26B | -1.79% | 1,091,499 | 10.85B |
| 234 | UFPT | UFP Technologies, Inc. | 2.22B | -2.15% | 105,730 | 631.64M |
| 235 | IMNM | Immunome, Inc. | 2.19B | 1.13% | 2,130,981 | 4.02M |
| 236 | PHVS | Pharvaris N.V. | 2.18B | -1.77% | 628,159 | - |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | 1.31% | 831,038 | 311.51M |
| 238 | VERA | Vera Therapeutics, Inc. | 2.14B | -1.72% | 1,731,217 | - |
| 239 | BFLY | Butterfly Network, Inc. | 2.14B | -2.90% | 6,971,282 | 112.14M |
| 240 | PGNY | Progyny, Inc. | 2.14B | 1.02% | 1,701,089 | 1.31B |
| 241 | AXGN | Axogen, Inc. | 2.12B | 0.39% | 1,378,168 | 251.17M |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.12B | -1.31% | 5,102,215 | 940.61M |
| 243 | RXRX | Recursion Pharmaceuticals, Inc. | 2.12B | -7.49% | 30,820,641 | 54.86M |
| 244 | ADUS | Addus HomeCare Corporation | 2.09B | 0.87% | 146,582 | 1.48B |
| 245 | MD | Pediatrix Medical Group, Inc. | 2.08B | 1.59% | 335,282 | 1.95B |
| 246 | VRDN | Viridian Therapeutics, Inc. | 2.08B | 0.33% | 2,443,706 | 71.13M |
| 247 | NEO | NeoGenomics, Inc. | 2.06B | 0.31% | 3,518,267 | 766.30M |
| 248 | VCEL | Vericel Corporation | 2.05B | -1.72% | 749,108 | 306.30M |
| 249 | ALVO | Alvotech | 2.02B | -3.16% | 668,876 | 494.61M |
| 250 | WGS | GeneDx Holdings Corp. | 2.02B | -1.17% | 734,628 | 454.43M |
| 251 | PRGO | Perrigo Company plc | 2.01B | -0.34% | 2,879,250 | 4.14B |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.00B | -3.80% | 1,503,076 | 1.14B |
| 253 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | 1.99% | 420,186 | 6.13M |
| 254 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 1.31% | 2,245,259 | - |
| 255 | SDGR | Schrödinger, Inc. | 1.97B | -3.30% | 3,079,461 | 259.04M |
| 256 | FTRE | Fortrea Holdings Inc. | 1.94B | -0.92% | 1,956,455 | 2.68B |
| 257 | INSP | Inspire Medical Systems, Inc. | 1.93B | -1.13% | 846,704 | 898.74M |
| 258 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 4.06% | 3,503,536 | 1.97B |
| 259 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | 0.41% | 2,078,641 | 98.34M |
| 260 | PVLA | Palvella Therapeutics, Inc. | 1.89B | 0.57% | 209,329 | - |
| 261 | VIR | Vir Biotechnology, Inc. | 1.88B | -3.47% | 3,071,115 | 303.23M |
| 262 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -2.96% | 3,593,756 | 208.78M |
| 263 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | 0.79% | 1,979,088 | 335.41M |
| 264 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.67% | 505,024 | 1.13B |
| 265 | ASTH | Astrana Health, Inc. | 1.84B | -3.42% | 351,050 | 3.84B |
| 266 | GPCR | Structure Therapeutics Inc. | 1.83B | -3.79% | 939,226 | - |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.83B | -2.40% | 6,351,934 | - |
| 268 | XNCR | Xencor, Inc. | 1.82B | 0.99% | 2,189,114 | 104.97M |
| 269 | LMAT | LeMaitre Vascular, Inc. | 1.82B | 0.42% | 272,909 | 262.43M |
| 270 | NVAX | Novavax, Inc. | 1.82B | -1.87% | 4,516,830 | 413.80M |
| 271 | URGN | UroGen Pharma Ltd. | 1.81B | -9.14% | 2,016,334 | 188.73M |
| 272 | ALHC | Alignment Healthcare, Inc. | 1.81B | 1.87% | 10,611,707 | 4.58B |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.81B | -5.07% | 560,107 | 245.82M |
| 274 | BHVN | Biohaven Ltd. | 1.80B | 0.42% | 2,698,561 | - |
| 275 | ALMR | Alamar Biosciences, Inc. | 1.80B | -6.70% | 955,503 | 100.42M |
| 276 | GENB | Generate Biomedicines, Inc. | 1.80B | 3.10% | 1,155,104 | 26.48M |
| 277 | ZYME | Zymeworks Inc. | 1.79B | -4.79% | 1,258,182 | 37.13M |
| 278 | SGRY | Surgery Partners, Inc. | 1.77B | -0.58% | 1,314,817 | 3.37B |
| 279 | NTLA | Intellia Therapeutics, Inc. | 1.77B | 7.60% | 13,959,318 | 59.51M |
| 280 | MESO | Mesoblast Limited | 1.75B | -1.36% | 239,027 | 120.25M |
| 281 | NUVB | Nuvation Bio Inc. | 1.74B | 1.85% | 6,852,760 | 169.90M |
| 282 | XRAY | DENTSPLY SIRONA Inc. | 1.73B | 1.76% | 6,198,582 | 3.64B |
| 283 | SEPN | Septerna, Inc. | 1.72B | 2.50% | 745,384 | 98.88M |
| 284 | PSNL | Personalis, Inc. | 1.72B | 0.37% | 1,467,437 | 69.67M |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.71B | -6.88% | 557,399 | 1.00M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.70B | -0.69% | 648,316 | 481.07M |
| 287 | FRNM | Freenome, Inc. | 1.70B | -1.37% | 947,904 | 35.41M |
| 288 | NVCR | NovoCure Limited | 1.66B | -3.00% | 2,956,790 | 699.19M |
| 289 | OCUL | Ocular Therapeutix, Inc. | 1.65B | 3.87% | 3,900,705 | 52.06M |
| 290 | ATEC | Alphatec Holdings, Inc. | 1.60B | 0.98% | 2,643,592 | 815.05M |
| 291 | OMCL | Omnicell, Inc. | 1.59B | -1.08% | 509,451 | 1.25B |
| 292 | CMPS | COMPASS Pathways plc | 1.59B | -1.88% | 2,832,392 | - |
| 293 | AZTA | Azenta, Inc. | 1.58B | 0.31% | 1,123,231 | 613.81M |
| 294 | ETON | Eton Pharmaceuticals, Inc. | 1.56B | -0.24% | 543,373 | 105.60M |
| 295 | QURE | uniQure N.V. | 1.56B | -2.59% | 1,812,593 | 18.67M |
| 296 | ARDT | Ardent Health, Inc. | 1.56B | 1.75% | 721,839 | 6.41B |
| 297 | BRVE | Braveheart Bio, Inc. | 1.56B | 2.74% | 389,175 | - |
| 298 | STOK | Stoke Therapeutics, Inc. | 1.55B | -1.40% | 692,275 | 27.59M |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 0.07% | 419,713 | 978.38M |
| 300 | KMTS | Kestra Medical Technologies, Ltd. | 1.53B | -2.72% | 379,727 | 106.73M |
| 301 | ABSI | Absci Corporation | 1.53B | -3.04% | 4,681,655 | 1.56M |
| 302 | KRSA | Korsana Biosciences, Inc. | 1.53B | 5.88% | 194,121 | - |
| 303 | PAHC | Phibro Animal Health Corporation | 1.52B | -0.85% | 238,731 | 1.52B |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.51B | -0.76% | 1,353,332 | 252.25M |
| 305 | INVA | Innoviva, Inc. | 1.51B | -0.90% | 612,292 | 440.00M |
| 306 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 2.69% | 5,393,775 | 717.00M |
| 307 | IMCR | Immunocore Holdings plc | 1.50B | -1.22% | 424,508 | 430.78M |
| 308 | PCRX | Pacira BioSciences, Inc. | 1.45B | 44.40% | 28,987,346 | 746.16M |
| 309 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | - | 3,914,623 | 5.49M |
| 310 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | 7.63% | 616,497 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.41% | 902,993 | 20.00M |
| 312 | RAPP | Rapport Therapeutics, Inc. | 1.43B | -3.27% | 236,778 | 20.00M |
| 313 | AGL | agilon health, inc. | 1.42B | -1.14% | 222,349 | 5.92B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.42B | -0.63% | 843,932 | 1.86B |
| 315 | PNTG | The Pennant Group, Inc. | 1.41B | 1.89% | 322,051 | 1.10B |
| 316 | GHRS | GH Research PLC | 1.40B | -2.85% | 332,163 | - |
| 317 | NUTX | Nutex Health Inc. | 1.40B | -3.76% | 177,747 | 846.72M |
| 318 | NKTR | Nektar Therapeutics | 1.39B | 1.34% | 1,742,290 | 54.59M |
| 319 | OMER | Omeros Corporation | 1.38B | 1.97% | 899,905 | 38.42M |
| 320 | ANAB | AnaptysBio, Inc. | 1.38B | 1.23% | 554,154 | 106.09M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.37B | -2.06% | 792,231 | - |
| 322 | AMN | AMN Healthcare Services, Inc. | 1.37B | -2.98% | 1,431,224 | 3.43B |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -0.64% | 208,037 | 1.30M |
| 324 | CNMD | CONMED Corporation | 1.35B | 1.99% | 298,768 | 1.37B |
| 325 | KARD | Kardigan, Inc. | 1.32B | 2.46% | 511,763 | - |
| 326 | CERT | Certara, Inc. | 1.32B | -3.57% | 4,124,881 | 421.75M |
| 327 | KLRA | Kailera Therapeutics, Inc. | 1.30B | -5.03% | 1,532,151 | - |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -1.75% | 595,117 | - |
| 329 | AAPG | Ascentage Pharma Group International | 1.28B | -2.88% | 11,981 | 94.61M |
| 330 | OMDA | Omada Health, Inc. | 1.27B | -0.34% | 932,426 | 309.76M |
| 331 | DMRA | Damora Therapeutics, Inc. | 1.27B | 1.58% | 278,115 | - |
| 332 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | 0.17% | 2,695,529 | - |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 0.68% | 177,327 | 804.27M |
| 334 | INNV | InnovAge Holding Corp. | 1.24B | -0.33% | 1,171,148 | 989.71M |
| 335 | REPL | Replimune Group, Inc. | 1.23B | -1.21% | 1,747,645 | - |
| 336 | SVRA | Savara Inc. | 1.23B | -1.02% | 2,514,606 | - |
| 337 | CRON | Cronos Group Inc. | 1.19B | -0.62% | 960,096 | 179.09M |
| 338 | NBTX | Nanobiotix S.A. | 1.17B | -6.42% | 116,619 | 13.15M |
| 339 | GDRX | GoodRx Holdings, Inc. | 1.15B | 3.38% | 1,062,028 | 785.23M |
| 340 | HROW | Harrow, Inc. | 1.14B | -0.33% | 566,000 | 275.59M |
| 341 | TRAX | First Tracks Biotherapeutics, Inc. | 1.14B | 4.64% | 1,411,478 | - |
| 342 | BCAX | Bicara Therapeutics Inc. | 1.14B | 5.12% | 1,253,642 | - |
| 343 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.74% | 732,303 | - |
| 344 | VOR | Vor Biopharma Inc. | 1.13B | 1.86% | 1,406,589 | - |
| 345 | JANX | Janux Therapeutics, Inc. | 1.13B | 3.24% | 1,500,797 | 24.00M |
| 346 | STAA | STAAR Surgical Company | 1.12B | 0.09% | 639,615 | 339.59M |
| 347 | LBRX | LB Pharmaceuticals Inc | 1.12B | 1.38% | 440,651 | - |
| 348 | MNKD | MannKind Corporation | 1.10B | -0.87% | 4,539,701 | 393.63M |
| 349 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | 1.21% | 422,785 | 730.02M |
| 350 | IRMD | IRADIMED CORPORATION | 1.10B | 0.54% | 91,607 | 86.34M |
| 351 | TNDM | Tandem Diabetes Care, Inc. | 1.09B | -1.04% | 2,899,008 | 1.04B |
| 352 | BVS | Bioventus Inc. | 1.07B | -0.63% | 385,604 | 581.85M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.04B | 3.15% | 1,459,365 | 1.65B |
| 354 | AORT | Artivion, Inc. | 1.03B | -1.85% | 314,361 | 471.47M |
| 355 | CSTL | Castle Biosciences, Inc. | 1.03B | 2.15% | 373,749 | 357.28M |
| 356 | PRCT | PROCEPT BioRobotics Corporation | 1.03B | -0.06% | 1,180,327 | 337.34M |
| 357 | OPK | OPKO Health, Inc. | 1.02B | -1.44% | 2,470,701 | 587.90M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.01B | -2.96% | 830,339 | 397.50M |
| 359 | IMTX | Immatics N.V. | 1.01B | -1.07% | 604,724 | 47.65M |
| 360 | TDOC | Teladoc Health, Inc. | 1.01B | -0.36% | 4,668,515 | 2.49B |
| 361 | ENOV | Enovis Corporation | 1.01B | -1.02% | 1,206,135 | 2.30B |
| 362 | ANL | Adlai Nortye Group Ltd. | 998.81M | 10.39% | 985,241 | 18.06M |
| 363 | CGEM | Cullinan Therapeutics, Inc. | 994.92M | -1.09% | 1,137,427 | - |
| 364 | HSTM | HealthStream, Inc. | 993.45M | 1.15% | 189,284 | 321.12M |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 992.45M | -2.46% | 492,090 | 1.04B |
| 366 | AKTS | Aktis Oncology, Inc. | 986.69M | -1.44% | 500,842 | 10.06M |
| 367 | LTGO | Latigo Biotherapeutics, Inc. | 980.57M | -4.70% | 265,092 | - |
| 368 | SPTX | Seaport Therapeutics, Inc. | 958.73M | -0.11% | 177,586 | - |
| 369 | AHG | Akso Health Group | 950.94M | -8.26% | 8,173 | 13.83M |
| 370 | ANRO | Alto Neuroscience, Inc. | 942.99M | 2.17% | 409,764 | - |
| 371 | KURA | Kura Oncology, Inc. | 935.87M | -1.41% | 1,644,097 | 77.23M |
| 372 | BBNX | Beta Bionics, Inc. | 917.55M | -3.60% | 1,113,846 | 119.01M |
| 373 | RIGL | Rigel Pharmaceuticals, Inc. | 910.08M | 1.52% | 216,634 | 276.79M |
| 374 | ALMS | Alumis Inc. | 902.16M | 2.95% | 2,853,082 | 7.40M |
| 375 | MLTX | MoonLake Immunotherapeutics | 900.43M | -1.76% | 3,717,335 | - |
| 376 | JBIO | Jade Biosciences, Inc. | 899.90M | 2.76% | 1,667,218 | - |
| 377 | CBLL | CeriBell, Inc. | 888.45M | -1.41% | 202,336 | 101.96M |
| 378 | GLUE | Monte Rosa Therapeutics, Inc. | 880.43M | 1.47% | 1,886,454 | 28.73M |
| 379 | ODTX | Odyssey Therapeutics, Inc. | 868.28M | 0.22% | 414,195 | 99.00K |
| 380 | SLBT | SL Science Holding Limited | 866.80M | 0.66% | 33,409 | 3.27M |
| 381 | CRVS | Corvus Pharmaceuticals, Inc. | 858.87M | -1.92% | 1,880,936 | - |
| 382 | QDEL | QuidelOrtho Corporation | 851.02M | 0.81% | 2,516,742 | 2.67B |
| 383 | SIBN | SI-BONE, Inc. | 845.73M | -1.20% | 762,744 | 213.60M |
| 384 | SANA | Sana Biotechnology, Inc. | 835.22M | 2.57% | 4,514,119 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 827.00M | -2.56% | 4,300,659 | 181.72M |
| 386 | SGP | SpyGlass Pharma, Inc. | 826.17M | 3.35% | 64,637 | - |
| 387 | AVBP | ArriVent BioPharma, Inc. | 823.93M | -1.07% | 2,153,903 | - |
| 388 | GMRS | GMR Solutions Inc. | 819.19M | 4.46% | 1,026,168 | 5.88B |
| 389 | ARDX | Ardelyx, Inc. | 814.84M | 0.31% | 6,538,198 | 450.89M |
| 390 | INMD | InMode Ltd. | 809.33M | 0.50% | 365,490 | 374.63M |
| 391 | AHCO | AdaptHealth Corp. | 809.13M | 3.15% | 3,036,854 | 3.36B |
| 392 | GERN | Geron Corporation | 783.82M | 1.67% | 10,156,117 | 204.56M |
| 393 | HELP | Helus Pharma Inc. | 783.21M | 2.00% | 1,116,368 | - |
| 394 | LXRX | Lexicon Pharmaceuticals, Inc. | 783.12M | - | 1,997,847 | 41.47M |
| 395 | VREX | Varex Imaging Corporation | 777.63M | 0.05% | 560,427 | 865.00M |
| 396 | IMMX | Immix Biopharma, Inc. | 771.83M | -1.90% | 1,288,913 | - |
| 397 | DNA | Ginkgo Bioworks Holdings, Inc. | 763.64M | -1.13% | 2,700,058 | 132.42M |
| 398 | APMD | Apnimed, Inc. | 758.51M | 1.00% | 331,966 | 115.12M |
| 399 | ANNX | Annexon, Inc. | 758.32M | -0.25% | 3,213,893 | - |
| 400 | OBX | Obsidian Therapeutics, Inc. | 756.10M | -7.27% | 517,058 | - |
| 401 | ATTO | Attovia Therapeutics, Inc. | 744.57M | -0.67% | 382,404 | 1.80M |
| 402 | IVA | Inventiva S.A. | 740.86M | -1.34% | 2,173,136 | 2.81M |
| 403 | ACHV | Achieve Life Sciences, Inc. | 739.87M | -0.69% | 1,108,853 | - |
| 404 | CADL | Candel Therapeutics, Inc. | 739.17M | -1.63% | 888,480 | - |
| 405 | VSTM | Verastem, Inc. | 734.47M | -1.88% | 3,051,369 | 87.53M |
| 406 | SLDB | Solid Biosciences Inc. | 731.28M | -0.44% | 1,308,062 | - |
| 407 | AVTX | Avalo Therapeutics, Inc. | 720.25M | -1.10% | 990,404 | 59.00K |
| 408 | COLL | Collegium Pharmaceutical, Inc. | 719.80M | 0.82% | 532,922 | 808.21M |
| 409 | DSGN | Design Therapeutics, Inc. | 719.06M | -1.71% | 399,317 | - |
| 410 | GYRE | Gyre Therapeutics, Inc. | 716.79M | -3.98% | 82,827 | 109.82M |
| 411 | PACB | Pacific Biosciences of California, Inc. | 714.91M | -15.44% | 24,125,742 | 159.27M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 701.60M | 0.87% | 970,761 | 92.01M |
| 413 | CTKB | Cytek Biosciences, Inc. | 696.71M | 0.37% | 1,712,462 | 206.71M |
| 414 | OLMA | Olema Pharmaceuticals, Inc. | 684.23M | -1.51% | 1,399,942 | - |
| 415 | WVE | Wave Life Sciences, Inc. | 683.76M | -1.98% | 2,664,283 | 65.37M |
| 416 | OABI | OmniAb, Inc. | 677.52M | 2.19% | 1,529,451 | 38.46M |
| 417 | AURA | Aura Biosciences, Inc. | 674.60M | 0.70% | 1,692,150 | - |
| 418 | MDXG | MiMedx Group, Inc. | 673.41M | 0.22% | 1,076,220 | 355.17M |
| 419 | FTH | Faeth Therapeutics, Inc. | 661.77M | 2.77% | 346,316 | - |
| 420 | PHR | Phreesia, Inc. | 661.68M | 1.52% | 695,070 | 507.79M |
| 421 | PHAR | Pharming Group N.V. | 661.41M | -1.24% | 5,116 | 366.48M |
| 422 | NVCT | Nuvectis Pharma, Inc. | 657.50M | -0.54% | 179,377 | - |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 653.22M | -0.72% | 486,767 | 136.07M |
| 424 | AVR | Anteris Technologies Global Corp. | 646.38M | -2.79% | 2,470,247 | 2.24M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 639.48M | 3.20% | 2,403,680 | 389.32M |
| 426 | PRME | Prime Medicine, Inc. | 636.90M | -8.21% | 7,721,123 | 4.07M |
| 427 | SGMT | Sagimet Biosciences Inc. | 632.51M | 0.45% | 1,229,047 | - |
| 428 | STLN | Starling Oncology, Inc. | 629.84M | -3.89% | 1,250,063 | 587.24M |
| 429 | CLYM | Climb Bio, Inc. | 623.18M | 1.31% | 1,065,325 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 621.43M | 2.10% | 499,852 | 86.17M |
| 431 | CBIO | Crescent Biopharma, Inc. | 604.35M | 4.67% | 301,206 | 11.88M |
| 432 | AQST | Aquestive Therapeutics, Inc. | 597.44M | 3.03% | 1,667,207 | 54.09M |
| 433 | WEAV | Weave Communications, Inc. | 591.19M | 0.27% | 2,139,491 | 257.79M |
| 434 | FLGT | Fulgent Genetics, Inc. | 572.87M | 1.22% | 427,857 | 323.93M |
| 435 | SLN | Silence Therapeutics plc | 572.59M | -3.16% | 1,109,564 | 615.00K |
| 436 | CRMD | CorMedix Inc. | 570.55M | 0.55% | 1,018,307 | 462.25M |
| 437 | KIDS | OrthoPediatrics Corp. | 568.67M | -3.11% | 268,320 | 252.72M |
| 438 | STTK | Shattuck Labs, Inc. | 568.06M | 0.09% | 2,486,606 | 1.00M |
| 439 | ETRA | Electra Therapeutics, Inc. | 566.79M | -1.42% | 408,048 | - |
| 440 | PHAT | Phathom Pharmaceuticals, Inc. | 566.34M | 4.70% | 1,334,351 | 239.66M |
| 441 | MNPR | Monopar Therapeutics Inc. | 563.69M | 0.24% | 185,505 | - |
| 442 | DBVT | DBV Technologies S.A. | 559.69M | -2.25% | 603,273 | 5.04M |
| 443 | ACRS | Aclaris Therapeutics, Inc. | 557.88M | 11.47% | 8,735,228 | 8.22M |
| 444 | EVO | Evotec SE | 544.65M | -2.48% | 94,375 | 819.47M |
| 445 | CTMX | CytomX Therapeutics, Inc. | 538.21M | -3.14% | 3,037,730 | 18.30M |
| 446 | BLSM | BlossomHill Therapeutics, Inc. | 536.53M | 1.63% | 165,150 | - |
| 447 | RGNX | REGENXBIO Inc. | 534.05M | 6.52% | 2,258,695 | 174.48M |
| 448 | OCS | Oculis Holding AG | 532.13M | 1.41% | 452,011 | 1.45M |
| 449 | NGNE | Neurogene Inc. | 530.30M | 2.44% | 509,293 | 925.00K |
| 450 | SSII | SS Innovations International, Inc. | 527.01M | -4.01% | 63,646 | 52.40M |
| 451 | DCTH | Delcath Systems, Inc. | 521.87M | -2.21% | 416,335 | 95.42M |
| 452 | EOLS | Evolus, Inc. | 515.19M | 0.78% | 1,077,997 | 316.49M |
| 453 | PBYI | Puma Biotechnology, Inc. | 514.65M | 1.63% | 356,518 | 231.24M |
| 454 | VALN | Valneva SE | 511.56M | -3.07% | 11,256 | 163.30M |
| 455 | DRUG | Bright Minds Biosciences Inc. | 508.68M | - | 67,922 | - |
| 456 | MPLT | MapLight Therapeutics, Inc. | 508.52M | -2.24% | 217,622 | - |
| 457 | ALT | Altimmune, Inc. | 505.75M | -2.26% | 3,568,122 | 31.00K |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 459 | PROK | ProKidney Corp. | 501.86M | 5.73% | 1,133,371 | 818.00K |
| 460 | TCMD | Tactile Systems Technology, Inc. | 501.07M | 0.45% | 368,791 | 350.31M |
| 461 | EPRX | Eupraxia Pharmaceuticals Inc. | 496.01M | -2.70% | 637,041 | - |
| 462 | CTNM | Contineum Therapeutics, Inc. | 495.85M | 3.53% | 845,255 | - |
| 463 | TLRY | Tilray Brands, Inc. | 491.80M | -3.36% | 8,877,179 | 963.10M |
| 464 | ARVN | Arvinas, Inc. | 491.05M | 0.81% | 1,016,635 | 316.70M |
| 465 | RZLT | Rezolute, Inc. | 486.72M | 5.94% | 2,197,638 | - |
| 466 | ALLO | Allogene Therapeutics, Inc. | 483.69M | -2.10% | 7,977,617 | 4.64M |
| 467 | MASS | 908 Devices Inc. | 477.40M | -1.95% | 447,946 | 60.84M |
| 468 | SENS | Senseonics Holdings, Inc. | 476.92M | -1.53% | 765,687 | 48.55M |
| 469 | AUTL | Autolus Therapeutics plc | 471.11M | -2.21% | 1,602,117 | 117.39M |
| 470 | SGHT | Sight Sciences, Inc. | 466.60M | - | 438,463 | 83.38M |
| 471 | CAPR | Capricor Therapeutics, Inc. | 465.69M | -1.11% | 2,513,373 | 11.13M |
| 472 | ASMB | Assembly Biosciences, Inc. | 464.63M | -0.57% | 288,403 | 74.85M |
| 473 | ANGO | AngioDynamics, Inc. | 464.16M | -20.86% | 3,063,625 | 325.38M |
| 474 | CERS | Cerus Corporation | 459.48M | -0.44% | 2,419,482 | 221.55M |
| 475 | OVID | Ovid Therapeutics Inc. | 457.00M | -0.85% | 1,646,763 | 1.58M |
| 476 | BWAY | BrainsWay Ltd. | 454.53M | -1.29% | 119,707 | 60.70M |
| 477 | AGMB | AgomAb Therapeutics NV | 454.07M | 4.77% | 225,174 | - |
| 478 | SPRY | ARS Pharmaceuticals, Inc. | 453.48M | 4.59% | 1,584,865 | 116.93M |
| 479 | TKNO | Alpha Teknova, Inc. | 453.13M | -3.10% | 252,865 | 43.70M |
| 480 | NRC | NRC Health | 451.02M | 0.99% | 99,235 | 140.00M |
| 481 | EVH | Evolent Health, Inc. | 447.71M | -4.35% | 2,882,639 | 2.10B |
| 482 | TECX | Tectonic Therapeutic, Inc. | 444.16M | 0.04% | 167,689 | - |
| 483 | PRTA | Prothena Corporation plc | 442.52M | 1.65% | 642,353 | 54.53M |
| 484 | KMDA | Kamada Ltd. | 440.12M | -1.46% | 67,837 | 191.85M |
| 485 | EDIT | Editas Medicine, Inc. | 436.17M | 3.27% | 4,639,256 | 47.01M |
| 486 | ENTX | Entera Bio Ltd. | 432.85M | -0.40% | 420,910 | 42.00K |
| 487 | DMAC | DiaMedica Therapeutics Inc. | 431.94M | 0.25% | 206,444 | - |
| 488 | NPCE | NeuroPace, Inc. | 424.93M | -2.98% | 142,564 | 106.99M |
| 489 | GLAS | Glass House Brands Inc. | 415.61M | -14.04% | 4,895,278 | 176.98M |
| 490 | AVIR | Atea Pharmaceuticals, Inc. | 413.46M | 2.89% | 350,918 | - |
| 491 | CTEV | Claritev Corporation | 412.33M | -2.80% | 196,314 | 994.67M |
| 492 | RCEL | AVITA Medical, Inc. | 412.25M | 2.15% | 347,122 | 75.63M |
| 493 | YDES | YD Bio Limited | 410.11M | -1.53% | 148,950 | 1.24M |
| 494 | EIKN | Eikon Therapeutics, Inc. | 406.24M | -0.53% | 847,139 | - |
| 495 | MYGN | Myriad Genetics, Inc. | 401.73M | -1.87% | 2,259,010 | 806.60M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 399.62M | 1.31% | 423,479 | 22.42M |
| 497 | ZURA | Zura Bio Limited | 395.77M | -0.96% | 2,694,414 | - |
| 498 | SRTA | Strata Critical Medical, Inc. | 395.45M | -4.49% | 1,134,679 | 255.98M |
| 499 | CARL | Carlsmed, Inc. | 383.60M | -2.29% | 62,780 | 63.30M |
| 500 | KYTX | Kyverna Therapeutics, Inc. | 382.19M | 0.16% | 1,316,919 | - |